Home > API & Intermediate > Inhibitors > Relugolix Manufacturers > Relugolix

Relugolix

CAS NO.： 737789-87-6

FOB Price： NEGOTIABLE Get Latest Price

Specification： 99%

Documentation： Get COA after inquiry

Lead Time： 14-30 days

Max Capacity： -

Packing： 1KG/BOTTLE

Product Detail

Properties

Relugolix

CAS:737789-87-6

Molecular formula: C29H29F2N7O5S

Molecular weight: 625.64600

Density: 1.442±0.06 g/cm3(Predicted)

Introduction: Relugolix, a small molecule gonadotropin-releasing hormone (GnRH) receptor antagonist, has the potential to be used for uterine fibroids, endometriosis, prostate cancer and other indications.

Structural formula:

Properties

Relugolix is an oral gonadotropin releasing hormone receptor antagonist

CAS No.

737789-87-6

Formula

C29H29F2N7O5S

Molecular Mass

625.64600

Exact Mass

625.19200

PSA

182.86000

Logp

3.69890

IUPAC

1-[4-[1-[(2,6-difluorophenyl)methyl]-5-[(dimethylamino)methyl]-3-(6-methoxypyridazin-3-yl)-2,4-dioxothieno[2,3-d]pyrimidin-6-yl]phenyl]-3-methoxyurea

Matter Classification

organic

Category

Melting Point

228 °C

Density

1.442 g/cm3(Predicted)

Appearance

White Powder

Acidity and Basicity

alkalinity

HS Code

29349990

Send your message to this supplier

To：

Shanghai Bocimed Pharmaceutical Co.,Ltd.

Not exactly what you want? One request, multiple quotations Get Quotations Now >>

Supplier's main products

Ruxolitinib Phosphate

Shanghai Bocimed Pharmaceutical Co.,Ltd.

12YRS

Business Type：

CRO

Country/Region：

Shanghai, China

Contacts：

Fang Rui

Position Title：

Manager of International Trade Department

Tel：

0086-21-58950312

Email：

bocimed@chemmail.net

Visit Factory

Get Free Samples

Less than 1KG required

b

Send Email

Relugolix

CAS:737789-87-6

Molecular formula: C29H29F2N7O5S

Molecular weight: 625.64600

Density: 1.442±0.06 g/cm3(Predicted)

Introduction: Relugolix, a small molecule gonadotropin-releasing hormone (GnRH) receptor antagonist, has the potential to be used for uterine fibroids, endometriosis, prostate cancer and other indications.

Structural formula: